Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. August 2015 16:10 ET | Quelle: Nivalis Therapeutics, Inc.

Nivalis Therapeutics Reports Financial Results for the Second Quarter 2015

– Phase 1b Clinical Study Completes Enrollment – – No Safety Signal Reported from Safety Monitoring Committee – – Phase 2 Initiation on Schedule for Q4...
23. Juni 2015 08:02 ET | Quelle: Nivalis Therapeutics, Inc.

Nivalis Therapeutics Announces Closing of Its Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

BOULDER, Colo., June 23, 2015 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (Nasdaq:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis, announced today the...
16. Juni 2015 21:52 ET | Quelle: Nivalis Therapeutics, Inc.

Nivalis Therapeutics Announces Pricing of Its Initial Public Offering

BOULDER, Colo., June 16, 2015 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc., (Nasdaq:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis, announced today...

Vorherige Seite